Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
301.50    -0.50 (-0.17%)
Bid:
302.00
Ask:
302.50
Spread: 0.50 (0.166%)
Market Cap: £177.99m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Share Buyback Programme

10 Apr 2025 07:01

RNS Number : 4134E
Treatt PLC
10 April 2025
 

10 April 2025

Treatt PLC

("Treatt" or the "Company")

Share Buyback Programme

Launch of Share Buyback Programme

Treatt PLC, the manufacturer and supplier of natural ingredients for the beverage, flavour and fragrance industries, is pleased to announce it will commence a share buyback programme (the "Share Buyback Programme"), as referenced in the Company's trading update released today.

Treatt has a strong balance sheet and the Board has considered the Share Buyback Programme as part of the Company's capital allocation framework, whilst also reflecting Treatt's strong cash performance together with the Board's confidence in Treatt's strategy and medium term outlook.

Details of the Share Buyback Programme

The Company has appointed its corporate brokers, Investec Bank plc ("Investec") and Peel Hunt LLP ("Peel Hunt") (together, the "Brokers"), to manage the share buyback programme to repurchase ordinary shares of 2 pence each in the capital of the Company (the "Ordinary Shares") on the Company's behalf from 10 April 2025, for a maximum aggregate consideration of £5 million (the "Buyback Amount"). The Share Buyback Programme will run until the earlier of the Buyback Amount being utilised in the repurchase of Ordinary Shares or the expiry of the 2025 Authority (defined below). Shares repurchased will be held in treasury at the Company's discretion for later reissue or cancellation.

Treatt has given irrevocable and non-discretionary instruction to Investec and Peel Hunt to conduct the Share Buyback Programme on its behalf. The Brokers will act as "riskless" or "matched" principals for the purposes of the Share Buyback Programme, within certain parameters, and will make trading decisions concerning the purchases of Ordinary Shares independently of the Company.

Shares purchased under the Share Buyback Programme will take place in open market transactions and in accordance with the general authority to purchase Ordinary Shares granted to the directors of the Company by its shareholders at the Company's annual general meeting in 2025 (the "2025 Authority"). The maximum number of Ordinary Shares which the Company is authorised to purchase under the 2025 Authority is 6,120,976. In accordance with the 2025 Authority, the maximum price (exclusive of expenses) which may be paid for an Ordinary Share is an amount equal to the higher of (i) 5% above the average of the middle market quotations for an Ordinary Share as derived from the London Stock Exchange Daily Official List on the five business days immediately preceding any Ordinary Shares being purchased and (ii) the higher of the price of the last independent trade and the highest current independent bid for Ordinary Shares on the trading venue where the purchase is carried out. Furthermore, in accordance with the 2025 Authority, the minimum price which may be paid for each Ordinary Share is 2 pence, being the nominal value of an Ordinary Share. The Share Buyback Programme will be conducted in accordance with Article 5(1) of Regulation (EU) 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended) ("UK MAR") and the provisions of Commission Delegated Regulation (EU) 2016/1052, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended), which deal with buyback programmes. The Share Buyback Programme will also be conducted in accordance with Chapter 9 of the Financial Conduct Authority's UK Listing Rules.

Treatt will make further regulatory announcements in respect of repurchases of Ordinary Shares as required.

 

For further information, please contact:

 

Treatt PLC

David Shannon, Chief Executive Officer

Ryan Govender, Chief Financial Officer

 

+44 (0) 1284 702500

Investec Bank Plc - Joint Corporate Broker

+44 (0) 20 7597 5970

Patrick Robb

David Anderson

Shalin Bhamra

 

Peel Hunt LLP - Joint Corporate Broker

+44 (0) 20 7418 8900

George Sellar

Andrew Clark

Finn Nugent

 

MHP - Financial PR

+44 (0) 20 3128 8100

Tim Rowntree

Eleni Menikou

Veronica Farah

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSSEFUEISEIL
Date   Source Headline
19th May 20225:03 pmRNSHolding(s) in Company
17th May 202211:50 amRNSHolding(s) in Company
13th May 20224:37 pmRNSHolding(s) in Company
13th May 20224:37 pmRNSNotification of Transactions of Director
12th May 20226:17 pmRNSHolding(s) in Company
12th May 20225:07 pmRNSHolding(s) in Company
12th May 202212:09 pmRNSNotification of Transactions of Director
11th May 20224:24 pmRNSHolding(s) in Company
11th May 20223:18 pmRNSNotification of Transactions of Director
10th May 20227:00 amRNSHalf-year Report
27th Apr 202210:28 amRNSDirector Declaration
11th Apr 20227:00 amRNSHalf Year Trading Update and Notice of Results
1st Apr 20221:59 pmRNSVoting Rights and Capital
30th Mar 20223:00 pmRNSNotification of Transactions of Director
24th Mar 20225:02 pmRNSNotification of Transactions of a PCA
22nd Mar 20224:55 pmRNSNotification of Transactions of Directors & PCA
22nd Mar 20229:10 amRNSDirector Declaration
8th Mar 202211:09 amRNSStandard Form for notification of major holdings
7th Mar 20222:19 pmRNSNotifications of Transactions of Director
7th Mar 202210:41 amRNSNotification of Transactions of Director
16th Feb 20227:00 amRNSAppointment of Chief Financial Officer
8th Feb 20225:06 pmRNSStandard Form for notification of major holdings
28th Jan 20223:29 pmRNSResult of AGM
28th Jan 20227:00 amRNSAGM Trading Update
25th Jan 20223:50 pmRNSStandard Form for notification of major holdings
20th Jan 202212:18 pmRNSConfirmation of AGM arrangements
17th Jan 20229:36 amRNSBoard Appointments
14th Jan 20229:30 amRNSVoting Rights and Capital
20th Dec 20216:16 pmRNSNotification of Transactions of Director
16th Dec 20215:50 pmRNSNotification of Transactions of Director & PCA
14th Dec 20219:07 amRNSAnnual Report
8th Dec 20214:49 pmRNSStandard form for notification of major holdings
8th Dec 20214:46 pmRNSStandard form for notification of major holdings
6th Dec 202112:32 pmRNSNotification of Transactions of Director
6th Dec 20218:58 amRNSStandard form for notification of major holdings
1st Dec 20215:25 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20215:20 pmRNSBLOCK LISTING SIX MONTHLY RETURN
30th Nov 20217:00 amRNSFull Year Results
26th Nov 20218:25 amRNSDirector Declaration
9th Nov 20215:11 pmRNSStandard form for notification of major holdings
18th Oct 20215:58 pmRNSStandard form for notification of major holdings
18th Oct 202110:29 amRNSStandard form for notification of major holdings
15th Oct 20214:25 pmRNSStandard form for notification of major holdings
11th Oct 20217:00 amRNSTrading Update
7th Oct 20214:07 pmRNSNotification of Transactions of a PCA
4th Oct 20214:54 pmRNSTotal Voting Rights
4th Oct 202110:30 amRNSDirector/PDMR Shareholding
21st Sep 20212:25 pmRNSChange of Registered Office
21st Sep 202111:50 amRNSDirector/PDMR Shareholding
21st Sep 20219:50 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.